Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Occuity is Crowdfunding
Occuity is delighted to offer retail investors, friends, family and supporters, who share our vision of non-invasive healthcare solutions, the opportunity to invest in Occuity, become equity shareholders and join us on our journey to improve the lives of hundreds of millions of people. Pre-Register below, to be the first to hear when our campaign goes live.
Why is Occuity Crowdfunding?
Occuity’s mission is to improve the lives of millions of people by developing non-invasive optical devices that detect and monitor chronic diseases like myopia, diabetes and Alzheimer’s — without the need for blood, needles, or discomfort.
Following major milestones — including CE-marking and global distribution of our first device, the PM1 Pachymeter — we’re excited to open a new investment round on Crowdcube.
This round offers existing shareholders and new investors the chance to join us as we prepare to launch the AX1 Axiometer™ — a breakthrough handheld device designed to measure axial length, a key metric for myopia management in children. With myopia projected to affect 50% of the global population by 2050, and almost 1 billion expected to develop high myopia, this is a fast-growing global health challenge.
Current desktop-based solutions are bulky, expensive, and not well suited for children. In contrast, the AX1 is portable, easy-to-use, child-friendly, and cost effective — making it a market-enabling solution for optometrists and global treatment providers alike. With strong early demand and launch expected in 2026, we believe the AX1 will unlock a significant new revenue stream.
Why Invest?
-
Support the global launch of the AX1 Axiometer™ — a high-potential product targeting a multi-billion-pound market
-
Help accelerate our mission to bring Oculomics — the science of detecting systemic disease through the eye — to life
-
Back a British healthtech business with patented technology, commercial traction, and a proven leadership team
-
Be part of our vision to change how the world sees health
This Republic (seedrs) campaign is a unique opportunity to help us scale, grow, and launch world-changing technology. By investing, you’re not just buying shares — you’re joining us on a mission to deliver impact at scale.
What is Crowdfunding?
Crowdfunding is the process of raising funds from a large number of people (the crowd). It enables businesses like Occuity to reach more people and raise more investment, whilst enabling people who for a variety of reasons like and support those businesses to invest in them and play a part in their future.
What is Equity Crowdfunding?
Republic Europe (seedrs) is an equity crowdfunding platform. This means that you will own equity (shares) in Occuity in return for your investment.
What are the Benefits of Equity Crowdfunding?
Equity crowdfunding allows you to buy into a business you believe in, and therefore have a financial share of the rewards of any potential success of that business.
When investing in early-stage businesses, you should be aware that your capital is at risk.
If the business performs well, the value of your shares may rise. If you decide to sell your shares one day, you will profit from the increase in value of those shares.
Say, for example, a company called StarTech, is raising money via equity crowdfunding, and you wish to invest. StarTech prices its shares at £10 per share, and you invest £100. This means you buy 10 StarTech shares (£100/£10 = 10). Your investment was a savvy one and StarTech grows fast over the next 5 years, such that the company’s value increases tenfold. The 10 shares you bought for £100 are now worth £1000.
As with all investing, equity crowdfunding comes with risks that investors should be aware of, such as loss of capital, illiquidity, and dilution.
About Occuity
What if we could spot chronic diseases like myopia, diabetes, and Alzheimer’s… before the damage they cause shows up as symptoms?
What if a simple scan of the eye could change the future of healthcare?
At Occuity, we’re turning that vision into reality.
We’re using the eye as a window on to the health of the body and are leaders in the burgeoning field of Oculomics: the science of detecting and monitoring systemic disease through the eye.
Our mission is bold: to improve the lives of hundreds of millions of people by making screening and monitoring for chronic diseases like myopia, diabetes, and Alzheimer’s accessible, painless and non-invasive.
We’re achieving this through a globally patented optical platform that uses a low-power beam of light to scan the eye — collecting data in seconds, with no blood, no needles, and no discomfort.
With 15 patents, and a strategic roadmap of handheld screening and monitoring devices, Occuity is building a platform for the future of preventative healthcare — with the potential to shift the paradigm from reactive treatment to early intervention.
We’re not just building medical devices.
We’re building the future of diagnostics.